Celecoxib versus diclofenac and omeprazole in reducing the risk of
recurrent ulcer bleeding in patients with arthritis.
Research has shown that a significant number of patients with atherosclerosis who have a history of peptic ulcer will develop
recurrent ulcers during treatment with clopidogrel.
Combination of a cyclo-oxygenase-2 inhibitor for prevention of
recurrent ulcer bleeding in patients at very high risk: a randomised double-blind trial.
This recommendation has been controversial, but current evidence suggests this strategy reduces the risk of
recurrent ulcer bleeding.
Prevention of
recurrent ulcer bleeding in H pylori-negative patients with arthritis
At the end of the study period, the probability of
recurrent ulcer bleeding was similar between groups, about 5%.
The current approach to the treatment of
recurrent ulcer disease involves the administration of antibiotics.
of the Chinese University of Hong Kong and his associates reported that
recurrent ulcer bleeding occurred at a significantly higher rate in 161 patients who received clopidogrel (Plavix) plus a placebo than in 159 patients who received aspirin plus esomeprazole (Nexium) during a median follow-up of 12 months (8.
pylori eradication is associated with a low rate of
recurrent ulcer hemorrhage and suggest that H.
Neither celecoxib nor diclofenac plus omeprazole completely protects against
recurrent ulcer complications in high-risk arthritis patients, reported Dr.
A combination of endoscopic and medical therapy is best for preventing
recurrent ulcer hemorrhages in patients with nonbleeding, adherent clots, said Dr.
Terms used for these noninfected canine ulcers have included indolent ulcers, canine
recurrent ulcers, refractory ulcers, persistent corneal erosions, boxer ulcers, and spontaneous chronic corneal epithelial defects (SCCEDs).
